TELMIKIND TRIO 6.25 (Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg))

Telmikind-Trio 6.25 Tablet is a combination medication aimed at managing hypertension, or high blood pressure, particularly in situations where a single treatment fails to provide adequate control. This medication works to effectively lower blood pressure, which consequently helps decrease the likelihood of experiencing severe cardiovascular events such as heart attacks and strokes. It is important to take this medication with food, and the specific dosage will be determined based on individual health conditions and how one responds to the treatment. Consistency is key, so it is advisable to take the tablet at the same time each day. Continuing the medication is vital unless your healthcare provider advises otherwise, as hypertension often presents no obvious symptoms, and discontinuing treatment can elevate the risk for serious complications. The formulation includes a diuretic component, which may increase urination; hence, it is best to avoid taking it within four hours of bedtime to minimize nighttime bathroom visits. To maximize the therapeutic benefits, this medication should be taken regularly, even in the absence of noticeable symptoms. Patients should maintain hydration to alleviate potential side effects such as muscle weakness, dry mouth, and significant thirst. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is essential to ensure the medication’s effectiveness and safety. Prior to starting treatment, it is crucial to inform the healthcare provider about any pre-existing liver or kidney issues, as well as all other medications being taken, especially those related to hypertension or heart health.